Lina Smith asked:


Mesothelioma treatment options for malignant mesothelioma can relieve pain and provide hope for the future. In many cases, new mesothelioma treatment options can increase mesothelioma life expectancy beyond original expectations. Even if advanced malignant mesothelioma has reached a seemingly incurable stage, participating in clinical trials gives a breath of hope to the future generations of mesothelioma cancer patients.

Treatment for malignant mesothelioma can start with surgery, although this is not always recommended in mesothelioma treatment options since older patients may have a difficult time with surgery. The objective is to remove the tumor, or at least most of it, and slow down the disease. With advanced mesothelioma, the tumor has often tragically spread throughout the body and has invaded life-giving organs, making surgery more risky than living with cancer itself. However in the early stages of malignant mesothelioma, a localized tumor is more likely to be successfully removed.

Radical surgery is a mesothelioma treatment option for advanced malignant mesothelioma that has been used in small clinical trials, but has resulted in almost half the patients (48%) living at least five years past their predetermined mesothelioma life expectancy date. “Extrapleural pneumonectomy” involves removing the internal body parts that mesothelioma cancer cells love to invade. Surgery removes the parietal pleura (pleural mesothelioma), the pericardium (pericardial mesothelioma) and the diaphragm, as well as the removal of a lung. This surgery is combined with pre and post operative chemotherapy and radiotherapy. Cancer Research UK is funding a “MARS” clinical trial (mesothelioma and radical surgery) to formally undergo pilot testing. Since the patients must be followed for five years, the results are not yet available and the success of these mesothelioma treatment options has yet to be discovered. UK medical reports do claim that US trial results have thus far demonstrated that a heavier dose of radiotherapy after the EPP surgery extends mesothelioma life expectancy.

Mesothelioma treatment options almost always include chemotherapy. Progress is seen in mesothelioma treatment when chemotherapy is combined with drug therapy. There are clinical trials for mesothelioma treatment options around the world that are seeking to find the chemotherapy and drug mix that can prolong mesothelioma life expectancy. Clinical trials are listed at many cancer organizations and research hospitals, and many seek mesothelioma patients wanting mesothelioma treatment options for advanced malignant mesothelioma. In advanced malignant mesothelioma, participating in a clinical trial can be a lifesaving mesothelioma treatment option.

Mesothelioma treatment options for advanced malignant mesothelioma can also be found in clinical trials for anti-angiogenic therapy. Anti-angiogenic mesothelioma treatment options are biological therapies that revolve around blood vessel growth. A cancer needs its own blood supply to grow. Two primary chemicals contribute to growth, VEGF and FGF-2. Mesothelioma patients with advanced malignant mesothelioma have higher levels of VEGF compared to patients suffering from other cancers. The theory the clinical trials are hoping to prove is that blocking VEFG will stop the blood vessel growth that supports the cancer growth.

Mesothelioma treatment options for malignant mesothelioma also includes clinical trials in phototherapy, immunotherapy, gene therapy and other therapies. Medical specialists are scrambling to find the mesothelioma treatment options for malignant mesothelioma that can protect and cure the projected increase in mesothelioma patients of the future. Participating in clinical trials can extend mesothelioma life expectancy and provide hope for future generations.



mesothelioma

Sarah Adams asked:


Although chemotherapy and surgery are the most common forms of treatment, participating in clinical trials can provide you with alternative mesothelioma treatment options. Increased awareness of mesothelioma and other asbestos-caused diseases has led to an increase on medical research to cure and control asbestos-caused cancers and related asbestos heart and respiratory diseases. Mesothelioma treatment and treatment options for advanced malignant mesothelioma are not limited to surgery and chemotherapy.

Advanced malignant mesothelioma clinical studies with Cisplatin, now often used with chemotherapy, proved Cisplatin to be effective. Drugs produce a medical benefit by themselves, and they can produce a different benefit when combined with other drugs – a chemical reaction that produces a third result. Mesothelioma clinical trials with Gemcitabine proved Gemcitabine to be ineffective. Perhaps the most common clinical trials and mesothelioma treatment options for advanced malignant mesothelioma involve chemotherapy and drug combinations. However, mesothelioma clinical trials using Cisplatin and Gemcitabine together are proving to be even more promising. Finding the right drug combinations to slow tumor growth and contribute to improved pain management is one of the fastest paths to wide-spread availability of new mesothelioma treatment options.

Anti-angiogenic therapies focus on natural body substances that affect the mesothelioma cancer’s growth, including the use of drugs made of these substances to inhibit cancer growth factors. Advanced malignant mesothelioma patients have a higher vascular endothelial growth factor than patients with other cancers.Anti-angiogenic therapy are a biological therapy based on interfering with the blood vessels that the cancer needs to survive.

Immunotherapy is also classified as a biological therapy. It concentrates on building immunity to the cancer cells. Immunotherapy can involve vaccines, and in cases of mesothelioma, these are likely to be injected in the pleural region. IL-2 is made naturally by the body, and clinical trials have demonstrated its success at treating mesotheliomas in the early stages, mesothelioma stages one and two, but not effective in treating advanced malignant mesothelioma.

Photodynamic therapy has gained increase attention in many medical fields for various treatment options, including mesothelioma treatment. Photodynamic therapy uses light and heat to kill cancer cells. It has been successful in treating other cancers.

Gene therapy is also a biological therapy and explores using the body’s natural substances to treat mesothelioma stages. The medical premise is to replace the genes in cancer cells with healthy genes. Oncogenes contribute to the fast spreading of the cancer cells and tumor suppressor genes stop cells from spreading.

Mesothelioma treatment for advanced malignant mesothelioma is slowly finding new mesothelioma treatment options. It takes years to evaluate the clinical significance of a clinical trial and medical research to prove that a mesothelioma treatment option is a promising and viable alternative. Thorough medical research on mesothelioma treatment contributes to safe medical treatment options being widely-available to the public. Mesothelioma in any of its stages is dangerous, but with researchers working together, mesothelioma treatment options will be safer and mesothelioma research will someday find a cure.

Advanced malignant mesothelioma can be treated by following one or more of the options mentioned above as it is necessary.



mesothelioma

Alan Haburchak asked:


eroidal anti-inflammatory drugs (NSAIDs), such as aspirin, are combined with Piroxicam and cisplatin (CDDP) they produce an anti-tumoral treatment of cancerous cells, specifically malignant mesothelioma cancer cells. These results, published in May 2008 in the Journal of Translational Medicine, are getting plenty of attention by both scientists as well as victims of mesothelioma cancer. Prior to this study, the prognosis for malignant mesothelioma cancer was grim, even at best, but now, researchers are breaking open a can of worms that may provide treatment for the deadly cancer caused by the inhalation of asbestos dust.

While this study offers a slice of hope for victims, the further research is required. Scientists with this study also found that the potential for determining a specific molecular target of mesothelioma cells, because of these drugs’ anti-tumor effects, could lead to advances in therapy treatments of the deadly cancer.

What is Malignant Mesothelioma Cancer?

There are several varieties of mesothelioma cancer, however, malignant mesothelioma is considered one of the most lethal. According to the study, “prognosis is poor and patients have a median survival of a few months in either treated or untreated cases.” Malignant mesothelioma is a rare cancer with malignant cancer cells forming on the sac lining of the chest or abdomen, according to the National Cancer Institute (NCI). It is often associated with exposure to airborne asbestos particles and fibers, which increases the risk of malignant mesothelioma developing in an individual.

Signs and Symptoms of Malignant Mesothelioma

Malignant mesothelioma is often marked by several symptoms including lumps in abdomen, weight loss, pain or swelling in the abdomen, pain under the rib cage and difficulties breathing. The cancer can also often cause fluid retention in the abdomen or around the lungs. The cancer often has symptoms similar to other conditions making misdiagnosis of the condition common.

Medical professionals have even admitted that malignant mesothelioma and lung cancer are very similar and differentiating between the two is difficult, however, there is an array of tests that physicians can use to increase the potential for a more accurate diagnosis. Tests for diagnosis may include the patient enduring physical exams, chest x-rays, biopsy of body tissues, getting a complete blood count (CBC), cytologic exam, which is an exam of cells under a microscope, or a bronchoscopy procedure where a bronchoscope is inserted into the nose or mouth for a better view of airways.

Diagnosing and Treating Malignant Mesothelioma

While treatments for mesothelioma are rare in and of themselves, it becomes increasingly difficult to treat malignant mesothelioma because of the severity of the condition. However, medical professionals take into consideration several factors prior to treatment to determine a patient’s prognosis. The following is a detailed list of these factors, according to the NCI:

* The stage of cancer, which includes stage I or localized malignant mesothelioma or advanced malignant mesothelioma that includes stage II, stage III and stage IV.

* The size of a tumor.

* Potential for tumor removal through a surgical procedure.

* The amount of fluid gathered in the chest or abdomen.

* A victim’s age, physical health and previous health issues.

* Type of mesothelioma cancer.

* Whether a cancer is diagnosed as reoccurring or not.

Often, cancer may spread through the lymph system, blood stream or other bodily tissues.

Treatments for malignant mesothelioma can range from surgery to therapy, including chemotherapy and biological therapy to clinical trials, although the outcome is based on the progression of the cancer and most often, individuals are not aware of their condition until it reaches an advanced and, usually, an untreatable stage.

Asbestos Exposure and What to Do

Asbestos is a mineral fiber that was used heavily in a range of building materials from vinyl flooring to insulation. It was prized for its inexpensive production costs and fire-retardant ability making it ideal among construction companies. Unfortunately, the inhalation of high levels of asbestos dust and fibers contributed to the development of mesothelioma cancer.

Unfortunately, this discovery came far too late, as millions of Americans working in the industry were exposed and millions more continue to remain at risk for exposure as asbestos still exists in homes, schools, apartment complexes and dozens of other types of buildings across the country. Individuals who believe they may have been exposed to asbestos particles and fibers should seek medical attention as soon as possible. If mesothelioma is the outcome it is advisable for a patient to receive consultation from an experienced mesothelioma attorney, as the potential for a mesothelioma lawsuit may exist with the opportunity for monetary compensation.

Sarah Adams asked:


Mesothelioma staging systems define mesothelioma stages; however, they are far more descriptive for pleural mesothelioma than for peritoneal mesothelioma. These systems have changed over time. Mesothelioma stages are important considerations in treatment and prognosis. By sectioning a progressive disease into stages, doctors can evaluate mesothelioma treatment options. Grouping similar variables for evaluation is beneficial to developing mesothelioma treatment options for different mesothelioma stages.

Mesothelioma cancer

In 1976 the Butchart staging system identified four mesothelioma stages for diffuse pleural malignant mesothelioma by location. At stage one, the tumor is in one side of the pleural lining. At stage two, the tumor is malignant and has entered both lungs, and has the potential to spread. In stage three, the tumor has entered the peritoneum (abdomen region), and at stage four, the cancer has spread through the blood stream.

In the 1980s Chahinian added detailed tumor stages, lymph node stages and metastases stages to the pleural mesothelioma staging system. This staging system is referred to as TNM and is used within elaborative staging systems. In 1990 the UICC (Union Internationale Contre le Cancer) expounded on Chahinian’s mesothelioma stages. The Butchart mesothelioma staging system in its originality is obsolete for mesothelioma life expectancy statistics, however other mesothelioma stages have been developed from it, and many cancer institutions modify it for their evaluative purposes.

The IMIG (International Mesothelioma Interest Group) in a 1995 Journal of Chest from the American College of Chest Physicians proposed international acceptance for a detailed universal staging system. This staging system demands precise tumor location, and is based on TNM and the International Lung Cancer Staging System.

Mesothelioma Lawsuits

Mesothelioma can be intimidating and frightening diagnosis to receive, especially if the mesothelioma is connected with occupational asbestos exposure, particularly mesothelioma may not even appear in an individual until many years or even decades after the initial asbestos exposure. In order to properly deal with this condition, it is important to address the medical treatment of the mesothelioma first. The prospect of a mesothelioma lawsuit can seem intimidating in and of itself, therefore this article is intended to assuage any fears about mesothelioma litigation by provide answers to questions commonly asked about mesothelioma lawsuits.

Mesothelioma lawyer

Once a treatment course has been determined and initiated, the next best step may be to inquire with a qualified mesothelioma lawyer about the possibility of mesothelioma litigation. If your case goes to trial, expect your lawyer to consult with other experts, a trial preparation specialist,  multimedia experts who can help present the evidence at trial in the most convincing manner, and witnesses who can bolster your own testimony in your mesothelioma trial. In an effort to avoid the cost

Nick Johnson asked:


Mesothelioma is a deadly cancer that is caused by asbestos exposure and there are no findings to suggest that this cancer is caused by other sources. Many of the victims who are diagnosed with Mesothelioma were workers who were not forewarned of the dangers of working with asbestos. People who are diagnosed with Mesothelioma should contact a Rhode Island Mesothelioma lawyer to help them with a Mesothelioma lawsuit that can get compensation for them to help with the medical and financial bills that are a result of the diagnosis.

Mesothelioma is caused by a person inhaling or swallowing asbestos fibers that then become lodged in the body. These fibers are virtually indestructible and the body’s immune system can’t break them down or get rid of them. Mesothelioma is a progressive disease and many people only live for one or two years after diagnosis. Mesothelioma cancer compromises the immune system as well as the area in which the cancer has set in.

In most cases, Mesothelioma is in the membrane that surrounds the lungs, called the pleura. However, Mesothelioma can also attack the lining of the heart or the abdomen. While this type of cancer is rare, approximately 3,000 new cases are reported each year in the United States.

Any level of exposure to asbestos can cause Mesothelioma, even infrequent exposure. Para-occupational exposure, which is secondary exposure, can also leave a risk for Mesothelioma to the families of workers who work with asbestos materials. The asbestos fibers easily cling to hair, clothing, shoes and skin and are brought home, dislodged and therefore create exposure in the home.

Most cases of Mesothelioma can be traced back to asbestos exposure directly in the work place. Approximatley 20 years ago, the products that contained asbestos and asbestos materials that were used in construction and manufacturing were in high demand and used frequently, even though it was known that asbestos exposure could lead to progressive diseases such as Mesothelioma.

Throughout the Second World War, naval ship yards were fabricating many ships for the war, using a lot of asbestos in the manufacturing process. The product was used for construction in buildings and for the manufacturing of automobiles as well. Until just recently, products and processes that use asbestos were unregulated, although the risk factors were known and safety precautions could be taken. Many companies still continued to utilize asbestos in their practices.

Many of the companies who used asbestos provided very little education or protection from asbestos exposure for their workers, leaving them now on the hook for compensating the victims of this dreadful and deadly cancer.

If you or someone you love has contracted Mesothelioma, it is important to contact a Rhode Island Mesothelioma attorney to find out if you have a case justifiable for a Mesothelioma lawsuit. The biggest problem with the onset of Mesothelioma symptoms and diagnosis and the exposure to asbestos is the long period of time, approximately 20 years, between the two. This makes it difficult to diagnose the cancer as well as find the company responsible for the exposure for your Rhode Island Mesothelioma lawyer.

The symptoms of Mesothelioma include fluid in the chest, chest pains, difficulty breathing, and coughing. Because of the nature of these symptoms and the fact that they are so similar to other medical problems, they are easily mistaken for other conditions, which can delay the diagnosis of Mesothelioma cancer. For most people, the diagnosis comes much too late – conventional treatments for cancer such as radiation and chemotherapy prove to have little or no effect on the progression of Mesothelioma cancer.

The majority of victims of Mesothelioma can blame companies and bosses for whom they worked for their asbestos exposure, and many of the companies knew the dangers of working with asbestos, and still failed to take any safety measures or precautions to reduce the exposure to this toxic material for their workers. Mesothelioma is a devastating cancer to people who have it and to their families, physically, emotionally and certainly financially.

A Rhode Island Mesothelioma lawyer can help you with a Mesothelioma lawsuit for yourself or a loved one. A qualified Mesothelioma lawyer can track down those responsible for your exposure and illness and can fight with a Mesothelioma lawsuit to gain financial compensation. While the compensation is no replacement for a life, it can certainly help cover lost wages, funeral expenses, medical costs and pain and suffering that are caused by Mesothelioma.



mesothelioma

Lina Smith asked:


Asbestos is a natural mineral that was once used in the construction and home improvement industries. It was put on ceilings when it was mixed with aertex, it was used to make surfaces semi flame resistant and it was also mixed with cement as it is very strong. At one point asbestos was seen as a revolution for these industries as it was just so versatile – it was also deadly. No one realised at the time that every time they were exposed to asbestos that they were taking their life in their hands and putting themselves in grave danger. Asbestos is now banned but its legacy lives on in the thousands of people who are feeling the after effects of being exposed to it over the years.

Exposure to asbestos is directly related to certain types of cancer, including peritoneal mesothelioma which is cancer of the membranes in the abdominal cavity. Peritoneal mesothelioma is the second rarest form of mesothelioma and each year it is responsible for around 20% of the cases of diagnosed mesothelioma. As exposure to asbestos is the only known cause of peritoneal mesothelioma there are two main ways that doctors believe that it can actually reach the abdominal wall. One way is through the digestion of asbestos fibres which is actually easy than most might think. Once in the digestive system the asbestos fibres get stuck in the peritoneum and over time this can result in peritoneal mesothelioma. The second way that asbestos gets to the abdomen is through the lymph nodes and lungs when asbestos is inhaled. In some cases pleural mesothelioma will result in peritoneal mesothelioma ad the asbestos moves through the lungs and into the abdominal cavity if left untreated and undiagnosed for some months.

Suspicion of peritoneal mesothelioma is usually made when a patient exhibits signs such as pain in the abdomen, chest or stomach and many suspect hernias are actually created by a tumour caused by peritoneal mesothelioma. Often a misdiagnosis that does not include peritoneal mesothelioma can be made and this can have severe repercussions on the life expectancy of a patient. It is usual for someone who is thought to have peritoneal mesothelioma to have to undergo many tests to get a correct diagnosis and these tests are imaging scans and tissue biopsies.

Patients who are found to have peritoneal mesothelioma do not have a good prognosis. However if a diagnosis of peritoneal mesothelioma is made early enough they could have surgery to remove the disease and some cases it can extend a patient’s life span for a few more years. If surgery is not an option then chemotherapy or radiotherapy can help although there is no guarantee that this will make much of a difference. It is essential that a person with peritoneal mesothelioma gets the right kind of treatment for any pain that they experience so that they are as comfortable as they can be. Peritoneal mesothelioma, like the other forms of mesothelioma is highly unpleasant and hard to live with.



mesothelioma